Curcumin and Glioblastoma: How Turmeric Can Be a Dietary Supplement Against Brain Cancer

Main Article Content

Kathryn Kennedy

Abstract

Imagine a brain tumor so aggressive that it can resist both chemotherapy and surgery, causing an alarming survival expectancy of only 12 to 18 months after diagnosis. This intimidating and complex disease is glioblastoma (GBM), the most common and deadliest brain tumor in adults (Yalamarty, et al., 2023). Researchers are urgently exploring new methods to prevent this serious disease. One particular intriguing dietary supplement researchers have studied as a means to reduce GBM tumor cell development is increased curcumin intake. Understanding how curcumin affects GBM cell mechanisms and how to incorporate turmeric into a diet are key components to taking advantage of this fascinating scientific breakthrough. 

Article Details

Section
Articles
Author Biography

Kathryn Kennedy, University of Illinois Urbana-Champaign

Kathryn Kennedy is a freshman studying Biology with minors in Health Technology and Spanish. She joined Brain Matters to learn more about neuroscience, psychology, and improve her writing and editing skills. Outside of the journal, she is involved in Global Medical Training and Education and Training 4 Health. She also dances with PSA Barkada, sings with the St. John's church choir, and plays guitar in her free time. Her career goal is to be a pediatrician.